Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma.

O'Connell, Kathleen; Thomson, Maurine; Morgan, Elizabeth; Henning, Joerg

O'Connell, Kathleen; Thomson, Maurine; Morgan, Elizabeth; Henning, Joerg.

Affiliation

O'Connell K; Department of Oncology, Animal Referral Hospital Brisbane, Sinnamon Park, Queensland, Australia.
Thomson M; Department of Oncology, Animal Referral Hospital Brisbane, Sinnamon Park, Queensland, Australia.
Morgan E; Department of Oncology, Animal Referral Hospital Brisbane, Sinnamon Park, Queensland, Australia.
Henning J; School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia.

Vet Comp Oncol ; 20(3): 613-622, 2022 Sep.

Article in En | MEDLINE | ID: mdl-35338560

Subject(s)

Dog Diseases; Lymphoma; Animals; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cyclophosphamide/adverse effects; Dog Diseases/drug therapy; Dogs; Doxorubicin/therapeutic use; Lymphoma/drug therapy; Lymphoma/veterinary; Prednisolone/therapeutic use; Procarbazine/therapeutic use; Treatment Outcome; Vincristine/therapeutic use

Key words

chemotherapy; comparative oncology; oncology; small animal; small animal internal medicine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dog Diseases / Lymphoma Type of study: Guideline / Prognostic_studies Limits: Animals Language: En Journal: Vet Comp Oncol Journal subject: MEDICINA VETERINARIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google